[Insulin sensitizer and hypertension]

Area of Science:

• Endocrinology
• Cardiovascular Medicine
• Metabolic Syndrome

Background:

• Insulin resistance syndrome theory links glucose intolerance, hyperinsulinemia, dyslipidemia, and hypertension.
• Proposed mechanisms for insulin resistance-induced hypertension include sympathetic activation, renal sodium retention, renin-angiotensin system stimulation, and calcium accumulation.
• Metabolic disturbances and insulin resistance are observed in patients with essential hypertension.

Purpose of the Study:

• To investigate the effects of insulin sensitizers on blood pressure.
• To explore the relationship between insulin resistance and hypertension.

Main Methods:

• Review of human and animal experiments examining insulin sensitizers and blood pressure.
• Analysis of studies involving troglitazone in essential hypertensives and fructose-fed rats.
• Examination of studies where troglitazone's effects were investigated in spontaneously hypertensive rats (SHR) and fructose-fed rats.

Main Results:

• Troglitazone has been shown to reduce blood pressure in some essential hypertensives and fructose-fed rats.
• Contradictory findings indicate troglitazone did not lower blood pressure in SHR and fructose-fed rats in other studies.
• The effect of insulin sensitizers on blood pressure remains inconsistent across different models.

Conclusions:

• The impact of insulin sensitizers on blood pressure requires further investigation due to conflicting experimental results.
• Clarification is needed on the precise role of insulin sensitizers in managing hypertension associated with metabolic syndrome.